Evidence map›Paper›PMID 30950329›Full record

ArticleEpigenetics2019

MiR-155-5p modulates HSV-1 replication via the epigenetic regulation of SRSF2 gene expression.

Ziqiang Wang, Kun Li, Xiaoxia Wang, Weiren Huang

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Frontiers in cellular and infection microbiology · 2022
    Article
  16. Review
  17. Innate and adaptive immune evasion by dengue virus.Frontiers in cellular and infection microbiology · 2022
    Review
  18. Article
  19. Histone crotonylation-centric gene regulation.Epigenetics & chromatin · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ziqiang Wanga State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine , Sun Yat-sen University Cancer Center , Guangzhou , P.R. China.
Kun Lic Department of Nuclear Medicine , Qianfoshan Hospital Affiliated to Shandong University , Jinan , P.R. China.
Xiaoxia Wangb Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital , First Affiliated Hospital of Shenzhen University , Shenzhen , P.R. China.
Weiren Huangb Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People's Hospital , First Affiliated Hospital of Shenzhen University , Shenzhen , P.R. China.
Shenzhen Second People's Hospital · CNShandong Provincial QianFoShan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A previous study reported that miR-155-5p knockout mice were more resistant to herpes simplex virus type I (HSV-1) infection. However, the exact underlying molecular mechanism remains to be elucidated. Here, we demonstrated that HSV-1 infection upregulates miR-155-5p expression. By binding to the promoter of serine/arginine-rich splicing factor 2 (SRSF2), which is an important transcriptional activator of HSV-1 genes that was previously reported by our group, and altering the histone modification located near the transcription start site (TSS) of the SRSF2 gene, miR-155-5p promotes the transcription of the SRSF2 gene, ultimately increasing viral replication and viral gene expression. Our results provide insight for an understanding of the roles and molecular mechanism of miR-155-5p in HSV-1 replication and the epigenetic control of SRSF2 gene expression.

Indexed as

Epigenesis, GeneticHeLa CellsHerpes SimplexHerpesvirus 1, HumanHumansMicroRNAsPromoter Regions, GeneticSerine-Arginine Splicing FactorsVirus ReplicationMicroRNAsMIRN155 microRNA, humanSerine-Arginine Splicing FactorsSRSF2 protein, humanepigenetic regulationgene transcriptionHSV-1Mir-155-5pSRSF2

Identifiers

PMID30950329
PMCPMC6557561
OpenAlexW2925756279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.